As of 9:30 AM on the 14th, Celltrion is trading at 268,000 KRW, down 0.92% from the previous day. This represents a 10.22% decrease compared to September 10. Celltrion is known as a manufacturer of protein and biopharmaceutical products.

Over the past five days, individual investors have net purchased 235,568 shares, while foreigners and institutions have net sold 278,552 shares and net purchased 31,182 shares, respectively.


On October 12, Celltrion became a market topic with a 3.8% increase following the news of approval for a COVID-19 antibody treatment preventive clinical trial.



※Source: AI Investment Assistant AI Lasso


※ This article was generated in real-time by an article automation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing